Implant Sciences Cp (IMSC) 0.5290 $IMSC
Implant Sciences Announced as Bronze Sponsor and Exhibitor for AVSEC World 2015 in Dublin, Ireland
PR Newswire - Mon Oct 26, 11:48AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it will exhibit at the 24th AVSEC World conference from October 26-28, 2015 in Dublin, Ireland. Implant Sciences will have its QS-B220 Desktop Explosives and Drugs Trace Detector available for demonstrations in booth 23 and is a bronze sponsor for the event.
Implant Sciences Continues to Win ECAC Follow-on Orders as Austrian Airports Place Additional Orders for QS-B220s
PR Newswire - Thu Oct 22, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has received a follow-on order for 16 additional QS-B220 Desktop Explosives Trace Detectors, for deployment to airports in Austria. Earlier this year, airports in Austria purchased and deployed 22 of Implant Sciences' QS-B220s for passenger and baggage checkpoint screening.
Following Successful Deployment, Airports in Belgium Place Follow-On Order for Implant Sciences' QS-B220s
PR Newswire - Wed Oct 21, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has received a follow-on order for 13 additional QS-B220 Desktop Explosives Trace Detectors, which will be deployed at airports in Belgium.
Implant Sciences Completes Shipments of 750 ETD Systems to Support New EU Aviation Regulations
PR Newswire - Tue Oct 20, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has completed shipment over 750 QS-B220 Desktop Explosives Trace Detectors across eleven European countries. These systems were sold between April and September, 2015, as EU airports sought to comply with new enhanced explosives screening requirements. Airport authorities that have selected Implant Sciences' trace detection systems include those located in France, the Netherlands, Norway, Finland, Germany, Belgium, Austria, Poland, the Czech Republic, Cyprus, and Romania.
Implant Sciences Announces Executive Promotions
PR Newswire - Fri Oct 16, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced the following executive promotions:
Incheon Airport Korea Purchases Additional QS-B220s as Implant Sciences Continues Expanding Its Aviation Presence Globally
PR Newswire - Wed Sep 30, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has shipped a follow-on order for additional QS-B220 desktop explosives trace detectors to Incheon International Airport, the largest airport in South Korea. The order, valued at over $500,000, was procured by Incheon International Airport Corporation, operator of Incheon International Airport. Last year, Incheon installed 12 QS-B220s to replace ETD systems from another manufacturer.
Implant Sciences Reports Fourth Quarter And Fiscal 2015 Financial Results
PR Newswire - Mon Sep 28, 3:05PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced financial results for the three months and fiscal year ended June 30, 2015.
Implant Sciences to Announce Fourth Quarter and Fiscal 2015 Financial Results
PR Newswire - Fri Sep 25, 3:01PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it will host a webcast and conference call on Monday, September 28, 2015 at 4:15 p.m. to discuss the financial results for the quarter and fiscal year ended June 30, 2015.
Implant Sciences Continues to Expand its Growing EU Market Share with QS-B220s Sold to Austrian Airports
PR Newswire - Tue Aug 25, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 22 of its QS-B220 desktop trace detectors to international airports in Austria, continuing its sales success in the European aviation market.
Implant Sciences Adds Romanian Airports to its list of Customers, Achieves Sales to a Total of 70 Countries Worldwide
PR Newswire - Tue Aug 11, 10:20AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that its QS-B220 desktop explosives trace detector has been selected in a Romanian airport tender. With this sale, Implant Sciences' trace detectors have been sold to customers in 70 different countries around the world, amounting to a total of approximately 4,400 units.
Implant Sciences Wins 50 Unit German Airport Order; Market Recognition of Superior Technology Fuels European Market Expansion
PR Newswire - Thu Jul 30, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced an important sale of 50 of its QS-B220 desktop explosives trace detectors to several international airports in Germany.
Implant Sciences Expands its Non-Contact Sampling Innovation with Award of its 19th Patent
PR Newswire - Wed Jul 29, 9:27AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced the award of its 19th patent. Titled "Trace Chemical Particle Release Nozzle" (Patent No. 9,067,219), this patent enhances Implant Sciences' non-contact sampling capability to allow for its integration and use in a wide range of high through-put screening deployment scenarios.
Implant Sciences Achieves First Major Sale into Drug Detection Market
PR Newswire - Wed Jul 22, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that, in a landmark sale for the company, it has sold 32 of its QS-B220 desktop explosives and drugs trace detectors across eight correctional facilities in Mexico. The units, which are replacing competing systems, will be deployed for drug detection.
Implant Sciences Wins Parisian Airport Tender for 178 ETDs
PR Newswire - Tue Jul 21, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 178 of its QS-B220 desktop explosives trace detectors to all three major Parisian airports.
45 Implant Sciences Explosives Trace Detectors Sold to Czech Republic International Airports
PR Newswire - Mon Jul 20, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 45 QS-B220 desktop explosives trace detectors across international airports in the Czech Republic.
Implant Sciences Announces Shipment of Additional $1.2 Million in Trace Detection Systems to Customers Globally
PR Newswire - Wed Jul 15, 9:22AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has shipped an additional approximately $1.2 million of its explosives trace detectors to customers around the world. The sales were comprised of both its QS-B220 desktop explosives and drugs trace detector and its QS-H150 handheld explosives trace detector. These systems were sold across four continents to be deployed in a variety of applications including mass transportation, cargo screening, infrastructure protection, and aviation security.
Implant Sciences Announces Results of 2015 Annual Shareholder Meeting
PR Newswire - Tue Jul 07, 10:36AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it held its annual shareholders meeting on July 1, 2015 at its headquarters in Wilmington, MA. At this meeting, the company's shareholders approved each proposal presented, including the election of the Director nominees to the Board of Directors. The Board and Implant Sciences' management believes this outcome conveys investor confidence in the current direction of the company.
In the Latest in a Series of Wins, Finland Airports Select Implant Sciences' QS-B220
PR Newswire - Tue Jun 30, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 58 of its QS-B220 desktop explosives trace detectors to Finnish Airports. The systems are scheduled to be deployed within the next several months.
Implant Sciences' QS-B220 Wins GSN Award for "Best Security Checkpoint"
PR Newswire - Thu Jun 25, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced today its QS-B220 desktop explosives and drugs trace detector has won the 2015 GSN Airport/Seaport/Border Security Award for "Best Security Checkpoint" (persons, baggage, parcels). The QS-B220 was also a finalist in two other categories: "Best Explosives/Narcotics/Contraband Detection" and "Best Cargo/Vehicle Screening".
Up to 304 Additional QS-B220s Sold to French Airports as Implant Sciences Deepens its Foothold in EU
PR Newswire - Thu Jun 11, 8:30AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has signed a contract for up to 304 of its QS-B220 desktop explosives trace detectors across 17 regional airports in France. The first 106 units are committed to being delivered over the next several months. Additional units are expected to be delivered through fiscal year 2016 and 2017. The sale was made through the Company's in-country, full-service distributor, Hi-Tech Detection Systems (HTDS).
Implant Sciences Announced as Bronze Sponsor and Exhibitor for AVSEC World 2015 in Dublin, Ireland
PR Newswire - Mon Oct 26, 11:48AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it will exhibit at the 24th AVSEC World conference from October 26-28, 2015 in Dublin, Ireland. Implant Sciences will have its QS-B220 Desktop Explosives and Drugs Trace Detector available for demonstrations in booth 23 and is a bronze sponsor for the event.
Implant Sciences Continues to Win ECAC Follow-on Orders as Austrian Airports Place Additional Orders for QS-B220s
PR Newswire - Thu Oct 22, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has received a follow-on order for 16 additional QS-B220 Desktop Explosives Trace Detectors, for deployment to airports in Austria. Earlier this year, airports in Austria purchased and deployed 22 of Implant Sciences' QS-B220s for passenger and baggage checkpoint screening.
Following Successful Deployment, Airports in Belgium Place Follow-On Order for Implant Sciences' QS-B220s
PR Newswire - Wed Oct 21, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has received a follow-on order for 13 additional QS-B220 Desktop Explosives Trace Detectors, which will be deployed at airports in Belgium.
Implant Sciences Completes Shipments of 750 ETD Systems to Support New EU Aviation Regulations
PR Newswire - Tue Oct 20, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has completed shipment over 750 QS-B220 Desktop Explosives Trace Detectors across eleven European countries. These systems were sold between April and September, 2015, as EU airports sought to comply with new enhanced explosives screening requirements. Airport authorities that have selected Implant Sciences' trace detection systems include those located in France, the Netherlands, Norway, Finland, Germany, Belgium, Austria, Poland, the Czech Republic, Cyprus, and Romania.
Implant Sciences Announces Executive Promotions
PR Newswire - Fri Oct 16, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced the following executive promotions:
Incheon Airport Korea Purchases Additional QS-B220s as Implant Sciences Continues Expanding Its Aviation Presence Globally
PR Newswire - Wed Sep 30, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has shipped a follow-on order for additional QS-B220 desktop explosives trace detectors to Incheon International Airport, the largest airport in South Korea. The order, valued at over $500,000, was procured by Incheon International Airport Corporation, operator of Incheon International Airport. Last year, Incheon installed 12 QS-B220s to replace ETD systems from another manufacturer.
Implant Sciences Reports Fourth Quarter And Fiscal 2015 Financial Results
PR Newswire - Mon Sep 28, 3:05PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced financial results for the three months and fiscal year ended June 30, 2015.
Implant Sciences to Announce Fourth Quarter and Fiscal 2015 Financial Results
PR Newswire - Fri Sep 25, 3:01PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it will host a webcast and conference call on Monday, September 28, 2015 at 4:15 p.m. to discuss the financial results for the quarter and fiscal year ended June 30, 2015.
Implant Sciences Continues to Expand its Growing EU Market Share with QS-B220s Sold to Austrian Airports
PR Newswire - Tue Aug 25, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 22 of its QS-B220 desktop trace detectors to international airports in Austria, continuing its sales success in the European aviation market.
Implant Sciences Adds Romanian Airports to its list of Customers, Achieves Sales to a Total of 70 Countries Worldwide
PR Newswire - Tue Aug 11, 10:20AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that its QS-B220 desktop explosives trace detector has been selected in a Romanian airport tender. With this sale, Implant Sciences' trace detectors have been sold to customers in 70 different countries around the world, amounting to a total of approximately 4,400 units.
Implant Sciences Wins 50 Unit German Airport Order; Market Recognition of Superior Technology Fuels European Market Expansion
PR Newswire - Thu Jul 30, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced an important sale of 50 of its QS-B220 desktop explosives trace detectors to several international airports in Germany.
Implant Sciences Expands its Non-Contact Sampling Innovation with Award of its 19th Patent
PR Newswire - Wed Jul 29, 9:27AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced the award of its 19th patent. Titled "Trace Chemical Particle Release Nozzle" (Patent No. 9,067,219), this patent enhances Implant Sciences' non-contact sampling capability to allow for its integration and use in a wide range of high through-put screening deployment scenarios.
Implant Sciences Achieves First Major Sale into Drug Detection Market
PR Newswire - Wed Jul 22, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that, in a landmark sale for the company, it has sold 32 of its QS-B220 desktop explosives and drugs trace detectors across eight correctional facilities in Mexico. The units, which are replacing competing systems, will be deployed for drug detection.
Implant Sciences Wins Parisian Airport Tender for 178 ETDs
PR Newswire - Tue Jul 21, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 178 of its QS-B220 desktop explosives trace detectors to all three major Parisian airports.
45 Implant Sciences Explosives Trace Detectors Sold to Czech Republic International Airports
PR Newswire - Mon Jul 20, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 45 QS-B220 desktop explosives trace detectors across international airports in the Czech Republic.
Implant Sciences Announces Shipment of Additional $1.2 Million in Trace Detection Systems to Customers Globally
PR Newswire - Wed Jul 15, 9:22AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has shipped an additional approximately $1.2 million of its explosives trace detectors to customers around the world. The sales were comprised of both its QS-B220 desktop explosives and drugs trace detector and its QS-H150 handheld explosives trace detector. These systems were sold across four continents to be deployed in a variety of applications including mass transportation, cargo screening, infrastructure protection, and aviation security.
Implant Sciences Announces Results of 2015 Annual Shareholder Meeting
PR Newswire - Tue Jul 07, 10:36AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it held its annual shareholders meeting on July 1, 2015 at its headquarters in Wilmington, MA. At this meeting, the company's shareholders approved each proposal presented, including the election of the Director nominees to the Board of Directors. The Board and Implant Sciences' management believes this outcome conveys investor confidence in the current direction of the company.
In the Latest in a Series of Wins, Finland Airports Select Implant Sciences' QS-B220
PR Newswire - Tue Jun 30, 8:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has sold 58 of its QS-B220 desktop explosives trace detectors to Finnish Airports. The systems are scheduled to be deployed within the next several months.
Implant Sciences' QS-B220 Wins GSN Award for "Best Security Checkpoint"
PR Newswire - Thu Jun 25, 8:00AM CDT
Implant Sciences Corporation (OTCQB:IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced today its QS-B220 desktop explosives and drugs trace detector has won the 2015 GSN Airport/Seaport/Border Security Award for "Best Security Checkpoint" (persons, baggage, parcels). The QS-B220 was also a finalist in two other categories: "Best Explosives/Narcotics/Contraband Detection" and "Best Cargo/Vehicle Screening".
Up to 304 Additional QS-B220s Sold to French Airports as Implant Sciences Deepens its Foothold in EU
PR Newswire - Thu Jun 11, 8:30AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced that it has signed a contract for up to 304 of its QS-B220 desktop explosives trace detectors across 17 regional airports in France. The first 106 units are committed to being delivered over the next several months. Additional units are expected to be delivered through fiscal year 2016 and 2017. The sale was made through the Company's in-country, full-service distributor, Hi-Tech Detection Systems (HTDS).
